-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

3347 Molecular Diagnosis of Hereditary Spherocytosis By Multi-Gene Target Sequencing in Korea

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
Program: Oral and Poster Abstracts
Session: 101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III
Monday, December 7, 2015, 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Qute Choi, MD1*, Jung Ah Kim2*, Kyong Ok Im, MT3*, Si Nae Park3*, Yoomi Park4*, Ju Han Kim4*, Hye Lim Jung, MD, PhD5*, Seon Young Kim, MD, PhD2*, Hee Young Shin6* and Dong Soon Lee2

1Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, South Korea
2Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, South Korea
3Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
4Division of Biomedical Informatics, Seoul National University College of Medicine, Seoul, South Korea
5Department of Pediatrics, Sungkyunkwan University School of Medicine, Seoul, South Korea
6Department of Pediatrics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea

Background: Hereditary spherocytosis (HS) is the most common cause of hereditary hemolytic anemia. Spherocytes formed by defective membrane proteins are selectively captured in the spleen and destroyed, leading to hemolytic anemia. Current tests used to diagnose HS focus on the detection of hemolysis or indirectly assess protein defects. Direct methods to detect protein defects are complicated and difficult to implement. Recent next-generation sequencing (NGS) methods enable large-scale gene mutation analyses to be used for such diagnoses. In this study, we investigated the patterns of genetic variation associated with HS to determine the molecular mechanisms underlying the condition. Specifically, we analyzed mutations in red blood cell membrane protein-encoding genes in Korean HS patients using NGS.

Methods: In total, 60 patients with HS were enrolled in this study. Targeted sequencing of 43 genes (17 membrane protein-encoding genes, 20 enzyme-encoding genes, and 6 additional candidate genes) was performed using the Illumina HiSeq platform and variants were called according to a data-processing pipeline.

Results: Of the 60 patients, 50 (83%) had one or more significant variants in a membrane protein gene. A total of 54 significant variants (8 previously reported and 46 novel) were detected in 6 membrane protein-encoding genes, i.e., SPTB, ANK1, SPTA1, SLC4A1, EPB41, and EPB42. The most variants (28) were detected in SPTB. Four significant variants, all of which were previously reported, were detected in genes encoding enzymes (ALDOB, G6PD, GAPDH, and GSR). Additionally, 5 previously reported variants were detected in UGT1A1. These results suggest 35 primer sets that can be used to diagnose HS.

Conclusion: This was the first large-scaled genetic study of Korean HS patients. These results clarify the pattern of genetic variation associated with HS in Korean patients. They will enable easier, more rapid diagnosis of HS.

Disclosures: No relevant conflicts of interest to declare.

See more of: 101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III
See more of: Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
See more of: Oral and Poster Abstracts
<< Previous Abstract | Next Abstract >>

*signifies non-member of ASH